H.R. 9791 aims to amend the Federal Food, Drug, and Cosmetic Act to modify the requirements for small businesses to qualify for a waiver from device fees associated with annual establishment registration. This change is intended to ease the financial burden on small businesses involved in the medical device industry, making it more feasible for them to comply with regulatory requirements.
Supporters of H.R. 9791 have praised the bill for its potential to foster innovation and growth within the small business sector of the medical device industry. They argue that reducing financial barriers will encourage more entrepreneurs to enter the market, ultimately leading to increased competition and better healthcare solutions for consumers.
Critics of H.R. 9791 have raised concerns that the bill may undermine regulatory oversight by allowing more businesses to bypass fees that contribute to the safety and efficacy of medical devices. They argue that this could lead to a decrease in product quality and pose risks to public health if not properly managed.
All donations are from employees of Applied Materials, Inc., which may have an interest in the amendment of device fees. This presents a medium risk of conflict of interest.
Top industries and organizations funding Scott Perry, from FEC data.
Source: FEC campaign finance records
